o-desmethylangolensin has been researched along with Carcinoma, Hepatocellular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, EJ; Kim, GH; Lee, JI | 1 |
1 other study(ies) available for o-desmethylangolensin and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Anticancer effects of O-desmethylangolensin are mediated through cell cycle arrest at the G2/M phase and mitochondrial-dependent apoptosis in Hep3B human hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Cyclin A; Cyclin B; Cytochromes c; G2 Phase Cell Cycle Checkpoints; Humans; Isoflavones; Liver Neoplasms; Mitochondria; Phytoestrogens; Proto-Oncogene Proteins c-bcl-2 | 2013 |